Insertion of the Escherichia coil lacZ gene into a ClaI restriction enzyme site of a 5-7 kb HindlII fragment of the fowlpox virus (FPV) genome resulted in the generation of stable recombinants. These recombinants produced plaques that were significantly smaller than those produced by parental FPV or by FPV recombinants containing the lacZ gene at other non-essential 
Introduction
The poxviruses have attracted much attention in recent years as vectors for the expression of foreign genes and for the construction of potential vaccines against animal diseases (Bostock, 1990; Tartaglia et al., 1990) . This is largely due to the relative ease with which large amounts of foreign DNA can be inserted into the viral genome by homologous recombination (Smith & Moss, 1983) , and to the strict cytoplasmic replication of the virus, which essentially rules out the possibility of integration into the host genome. Most of the attention has focused on vaccinia virus, the prototype of the genus Orthopoxvirus (Hruby, 1990; Moss, 1991; Mahr & Payne, 1992) , because of its wide host range and relatively well defined molecular biology (Moss, 1990a; Goebel et al., 1990) .
The Avipoxvirus genus has a host range which is restricted to avian species, although abortive infection can apparently be initiated in mammals Wild et al., 1990; Taylor et al., 1991 Taylor et al., , 1992 . As a result of this limited host range, there is little or no risk of avipox vaccines spreading to humans or to t Permanent address: Biological Science Institute, Nippon Zeon Co. Ltd., Kawasaki 210, Japan.
The DNA sequence data reported in this article have been deposited with the GenBank database and assigned the accession number M88588. mammalian livestock and wildlife. Commercial vaccines against fowlpox virus (FPV, the genus prototype) are available, and are derived from attenuated FPV or pigeonpox virus (PPV) (Tripathy, 1991) . These viruses show promise as safe vectors for live recombinant poultry vaccines against other avian diseases, and have been used successfully to immunize chickens against several pathogens, including Newcastle disease virus Yanagida et al., 1990; Taylor et al., 1990; Edbauer et aL, 1990; Boursnell et al., 1990a, b; Letellier et al., 1991) , avian influenza virus Boyle & Coupar, 1988; Beard et al., 1991) , infectious bursal disease virus (Bayliss et aI., 1991 ) and Marek's disease virus .
Stable recombinants can only be obtained if the foreign gene is inserted into a site which is non-essential for viral growth in cell culture. One approach is to place the insert into a gene which is known to be, or suspected of being, non-essential. Such is the case with the viral thymidine kinase (TK) gene, the most common insertion site in use today. Another approach is to target the foreign gene into the short intergenic regions found between most pairs of adjacent genes in the poxvirus genome . Both of these methods require prior sequence knowledge of the DNA fragment to be used. An alternative procedure for finding appropriate non-essential sites for the creation of recombinants has been used by us. A marker gene, the Escherich& coti lacZ gene, was inserted into convenient restriction endonuclease sites of cloned FPV genome fragments, chosen randomly. Some of the resulting recombinant FPV were unstable, indicating that the disruption of an essential gene had occurred. Other sites, however, yielded recombinants which stably expressed the lacZ gene. One of these non-essential sites, designated position 25, consists of a unique ClaI site in a 5.7 kb HindIII fragment. We have observed that position 25 recombinants consistently display a small plaque phenotype (Yanagida et aI., 1992) .
Poxviruses produce two types of infectious progeny (Boulter & Appleyard, 1973; Moss, 1990b) . The majority of particles exist as intracellular naked virions (INVs). The INVs of vaccinia virus are fairly well characterized, and consist of a single lipid layer surrounding a viral core and lateral bodies. INVs are infectious, but appear to play little or no role in the spread of infection, since they remain in the infected cell until its eventual disintegration. A small minority of the INVs acquire a double layer of lipid membrane derived from the Golgi apparatus of the cell (Hiller & Weber, 1985) . The outermost of these layers then fuses with the cell membrane to release extracellular enveloped virions (EEVs). The EEVs have been shown to be important in the dissemination of infection both in vitro and in vivo (Payne, 1980) . Little is known about the roles of INVs and EEVs in Avipoxvirus infections, although some antigenic distinctions have been shown between intracellular and extracellular virions, at least for some strains of FPV (Fernandes et al., 1981; Maiti et al., 1991) . An ultrastructural study reported that EEVs of FPV may result from a more traditional budding process in which INVs acquire an envelope by budding directly through the plasma membrane of the cell (Arhelger & Randall, 1964) .
We report here the sequence analysis of a portion of the FPV genome which includes position 25. An open reading frame (ORF), potentially encoding a 74K polypeptide, is disrupted by lacZ insertion. This ORF shows significant homology to vaccinia virus ORF F 12L, which encodes a product showing some characteristics of membrane proteins , but whose function is currently unknown. In this paper we present evidence that this FPV ORF encodes a polypeptide which is involved in virus envelopment or release, and that disruption of this ORF results in the observed small plaque phenotype.
Methods
Cells and viruses. Primary chick embryo fibroblast (CEF) cultures were prepared from 11-day-old RPRL line 0 white Leghorn embryos raised in our laboratory, using the method of Solomon (1975) . CEF cultures were grown in Leibovitz-McCoy medium supplemented with 4 % calf serum and antibiotics.
A large plaque variant of a vaccine isolate of FPV (Nazerian et al., 1989) , originally obtained from Dr Roland Winterfield (Purdue University, West Lafayette, Ind., U.S.A.), was used as the parental virus from which recombinants were constructed. Two non-essential insertion sites (designated positions 25 and 29) were employed in the construction of plasmid transfer vectors. The sites are located on two randomly selected DNA fragments, a 5.7 kb HindlII fragment and a 7-3 kb EcoRI fragment, respectively. These DNA fragments were derived from the NP vaccine strain (Shionogi & Co, Ltd.) of PPV . The restriction enzyme cleavage patterns of PPV are similar to those of FPV (Schnitzlein et al., 1988; Ogawa et al., 1990) , and DNA sequencing of several homologous regions in our laboratory (totalling about 5-2 kb) indicates that these PP¥ and FPV genes are about 99'9 % identical at the nucleotide level (unpublished data). One such region of overlapping sequence data is the 2598 bp HindIII-Pstl fragment which comprises the region of homology between the transfer vector pNZ1025 (Fig. 1) and the FPV genome. The two virus DNAs are completely identical within this region, which is significant because it eliminates the possibility of generating a chimeric FPV-PPV by homologous recombination. . A new pUC multiple cloning site was inserted into the unique ClaI site of pNZ 124S or between two EcoRV sites of pNZ133S, and a gene cassette (Yanagida et al., 1990; Ogawa et al., 1990) , consisting of the E. coli lacZ gene driven by the vaccinia virus P7.5 promoter (Venkatesan et al., 1981) , was cloned into it, yielding plasmids pNZ1025 ( Fig. 1 ) and pNZ1029 (Yanagida et al., 1990) , respectively. These transfer vectors were used to generate recombinant viruses fNZI025 and fNZ1029, respectively.
Generation and purification of recombinant FPV. CEF monolayers (about 1 x 10 r cells) were infected with FP¥ at a multiplicity of 0.1 and incubated for 5 h in serum-free medium. Cells were trypsinized, washed twice in Saline G (0.14 ~-NaCI, 5 mM-KC1, 1.1 mM-Na2HPO4, 1.5 mM-KH2PO4, 0'5 mM-MgC12 and 0.011% glucose), and resuspended in 0.7 ml Saline G. This cell suspension was mixed with 10 lag of CsC1-purified transfer vector DNA in 0"1 ml of Saline G and subjected to electroporation at 300 V (750 V/cm), 330 laF, low resistance, using a Cell@orator Electroporation System (Gibco-BRL). After 10 min, transfected cells were plated onto a single 60 mm culture dish and incubated at 37 °C. After 3 days incubation, these cells were harvested by scraping and disrupted by multiple cycles of freezing and thawing to release progeny virus.
Recombinant FPVs were identified and purified using a modification of the method described in Dhawale et al. (1990) . Briefly, dilutions of the cell lysates were assayed on CEFs with an overlay of medium containing 0-8 % Bacto agar and lacking phenol red pH indicator. Total plaques were quantified after 6 days. Recombinants, which expressed the lacZ gene, were identified by staining with 10 ml of a second agar overlay which contained 600 lag/ml Bluo-gal (Gibco-BRL), a chromogenic substrate for fl-galactosidase. The following day blue recombinant plaques were picked into a small volume of medium, disrupted, and used to infect the next round of CEF cultures. Plaque purification was continued until only blue plaques were detected.
Southern blot hybridization analysis, using standard procedures (Sambrook et al., 1989) , was performed on DNA from cells infected with recombinant FPVs to confirm the genomic structure of the virus.
Single-step growth curve for production of intracellular and extracellular virions. Confluent monolayers of secondary CEF cultures were infected with FPVs at a multiplicity of 10. After an adsorption period of 90 min at 37 °C, the inoculnm was removed and monolayers were washed three times with medium. Fresh medium was added and plates were incubated at 37 °C. At various times, plates were removed in order to determine titres of intra-and extracellular virus. The medium was assayed directly for extracellular virus, whereas intracellular virus was titrated from washed monolayers, disrupted in 2 ml of medium by freezing and thawing followed by mild sonication.
CsCl gradient analysis of[ ~HJthymidine-labelled FPV.
Parental FPV and recombinant fNZ1025 were labelled with 5 laCi/ml of [ZH]-thymidine (NEN) for 70 h, and intra-and extracellular virions were prepared separately and analysed by CsCl density gradient centrifugation. The procedure was essentially as described in Schmutz et al. (1991) , except that cells were disrupted by mild sonication rather than by Dounce homogenization, and CsC1 gradient centrifugation was for 3 h at 36000 r.p.m, in an SW41 rotor.
Sequencing. Restriction enzyme fragments were subcloned from plasmid pNZ124 into the phage vectors M13mpl8 and M13mpl9. Single-stranded template was prepared and sequenced by the dideoxynucleotide chain termination method using [~SS]dATP (NEN) and 5 Sequenase kits (United States Biochemical), as suggested by the manufacturer. Both strands of DNA were sequenced completely. Sequencing data extend across all restriction enzyme sites used in subcloning.
Computer analysis. Data from sequencing gels were entered and edited using the program EditSeq and compiled into contiguous stretches using SeqMan (both from DNASTAR). Restriction maps and cloning strategy diagrams were prepared using Gene Construction Kit (Textco). Homology searches against GenBank release 69.0 (IntelliGenetics) and the Protein Identification Resource version 29.0 (National Biomedical Research Foundation), and hydrophobicity plots were performed using MacVector (International Biotechnologies). These programs were run on a Macintosh SE/30 computer (Apple Computer). Final alignment of amino acid sequences was performed using the program GAP of the University of Wisconsin Genetics Computer Group (Devereux et al., 1984) . Percentage identity between peptides was calculated by dividing the number of identical amino acid residues by the total length of the aligned region (including gaps).
Mapping within the FPVgenome. A recombinant FPV was generated, exactly analogous to fNZ1025, except that the inserted lacZ gene contains an internal NotI site. This recombinant was designated fNZ1025-Not. The Notl site was engineered into the central portion of the lacZ gene by site-directed mutagenesis (ACGCGCCCGCTG ACGCGGCCGCTG), and does not alter the peptide sequence encoded by the gene (TRPL).
DNA extracted from purified fNZ1025-Not virions was digested with NotI and analysed by pulsed-field electrophoresis and Southern blot hybridization, using the cloned TK gene of FPV as a probe. Conditions for pulsed-field electrophoresis were 18 h at 14 °C with a 10 to 60s ramped pulse at 200V, using 1% agarose gels in 0.5x Tri~borate-EDTA buffer, in a CHEF-DR lI apparatus (Bio-Rad). A 2 ladder (New England Biolabs) was used as a molecular size marker.
Results
The E. coli lacZ gene, driven by the vaccinia virus P7.5 promoter, was inserted into two different positions in the FPV genome (Yanagida et al., 1990) by homologous recombination. Insertions at both sites yielded stable recombinants which produced plaques that stained blue in the presence of Bluo-gal, and which could easily be plaque-purified and amplified. Recombinant FPV from one of these insertion sites (fNZ 1029) gave plaques which were similar in size to those of the parental virus. However, recombinants obtained from insertions at the other site (fNZ1025) produced plaques which were significantly smaller (Fig. 2b) . In one e×periment, the average diameter of 50 fNZ1025 plaques was 1-7 mm, whereas fNZ1029 and parental virus both gave average diameters of 2.5 mm. The structure of the genome of fNZ1025 was confirmed by Southern blot analysis (data not shown). Three probes were employed: (i) a clone of FPV DNA flanking position 25 (pNZ124S), that showed an appropriately sized insert into this region of the genome, (ii) pBR322, which showed that plasmid sequences are not present in the recombinant and (iii) a fragment of the lacZ gene, which showed that lacZ is inserted into only one site (the correct site) in the genome of fNZ1025. Insertion of other genes at position 25 VIR 74 invariably resulted in small plaque recombinants, demonstrating that this phenotype is caused by disruption of ORF 2, and that it is independent of the type or orientation of the inserted gene (data not shown).
To determine whether the production of small plaques by fNZ1025 was due to a decrease in the number of infectious viruses released from infected cells, single-step growth curves for fNZ1025 and parental FPV were compared. The results are shown in Fig. 3 . The two viruses produced virtually identical titres of cell-associated progeny (a). However, titration of the culture medium (b) revealed that the recombinant fNZ1025 produced about sixfold fewer infectious extracellular progeny at 72 h post-infection (p.i.), relative to the parental virus. This difference between the two viruses was apparent as early as 16 h p.i., when progeny were first detected, and increased in magnitude throughout the course of infection.
To determine whether the decrease in titre of released virus was due to a decrease in the number of physical particles or to a lower infectivity of the released particles, progeny virions from fNZ1025 and parental FPV were metabolically labelled with [aH] thymidine. Released and cell-associated particles were banded separately on CsC1 gradients and the amount of incorporated label was quantified (Fig. 4) . The two viruses produced virtually identical amounts of INV, which banded at a density of 1.270 g/ml (a). However, the recombinant fNZ1025 produced only about half as many EEVs, which banded at a density of 1.240 to 1"243 g/ml, as parental FPV (b). Therefore, the decrease in titre seen in Fig. 3 can be acounted for, at least in part, by a decrease in the number of released physical particles.
Given the unusual phenotype, it was of interest to determine what FPV gene was disrupted in fNZ1025, and whether a homologous gene is present in vaccinia virus. Accordingly, a 3178 bp portion of the 5-7 kb HindIII fragment of pNZ124 was subcloned into M13 vectors and sequenced. Analysis of the ORFs (Fig. 5 ) reveals that the ClaI restriction site, into which lacZ was inserted, is located 444 bp from the 5' end of a 1893 bp long ORF (ORF 2, bases 794 to 2685). The predicted protein product of this gene is a 74K polypeptide with eight potential N-glycosylation sites, which shows 24 % amino acid identity to the predicted product of the vaccinia virus F12L ORF (Fig. 6) .
In addition to the large central ORF (ORF 2 in Fig. 5 ), two partial ORFs were identified at the ends of the sequenced fragment. The 5' end of the DNA (ORF 1, bases 1 to 756 in Fig. 5 ) potentially encodes the carboxylterminal two-thirds of protein which is clearly related (38 % amino acid identity) to the vaccinia virus p37K major envelope antigen (Hirt et al., 1986) , the product of the vaccinia virus F13L ORF. The 3' end of the sequenced DNA fragment (ORF 3, bases 2726 to 3178 in Fig. 5 ) contains an ORF which potentially encodesr a product of at least 150 amino acids. Based on its position relative to the F13L and F12L homologues, this ORF might be expected to encode the amino-terminal portion of an F11L homologue. Despite a few short regions of DNA and amino acid similarity, it was not possible to demonstrate homology between this partial ORF and vaccinia virus F l l L , other vaccinia virus ORFs, or sequences in the GenBank and NBRF-PIR databases.
The location of the position 25 insertion site within the FPV genome was determined in two ways. Firstly, Southern blot hybridization analysis (not shown) indicates that the 1-25 kb HindIII-ClaI portion of the 5.7 kb HindIII fragment is within the 5'7 kb PstI M fragment seen in the FPV map of Coupar et al. (1990) . Further Fig. 3 . Single-step growth curves. The yield of cell-associated (a) and released (b) progeny virus was determined at various times after infection as described in Methods. The data points represent the average of two separate experiments, each of which was performed in duplicate. Parental FPV (.), fNZ1025 (0). analysis using BamHI and EcoRI, for which partial maps were shown, supports assignment of the HindlII fragment to this position. This location is near the centre of the 300 kb FPV genome, about 132 to 138 kb from the left end in the published map (as shown in Fig. 1) . As a point of reference, the viral TK gene is about 90 kb from the left end in this map. Since we employed a strain of FPV that is different from the Australian strain used in the construction of the published map, we have confirmed the genomic location of the position 25 insertion site using a second method. Another recombinant FPV, designated fNZ1025-Not, was constructed. This virus is identical to fNZ1025, except that it contains an engineered NotI site within the inserted lacZ gene. DNAs from purified parental FPV and fNZ1025-Not virions were digested with NotI and analysed by pulsed field electrophoresis. Parental FPV yields two bands under these conditions: a large band of about 285 kb, which represents the bulk of the genome, and a band of about 8 kb, which is probably a doublet resulting from NotI sites within the terminal inverted repeats [the Australian strain has terminal Nod fragments of 4-6 kb (Coupar et al., 1990) ]. In the case of fNZ1025-Not, the 285 kb band is replaced by two bands of approximately 125 and 160 kb, which is consistent with the previous estimate of the location of position 25. 
Discussion
In this report we describe an ORF in the genome of FPV which is non-essential for growth in tissue culture, but whose disruption results in a small plaque phenotype. Recombinant FPVs that contain the E. eoli lacZ gene inserted into this site produce normal amounts of INVs, but reduced levels of EEVs. The reduction in EEV titre correlates with a decrease in the number of [3H]thymidine-labelled physical particles released into the medium. In spite of this decrease in EEV production, position 25 recombinants are similar to recombinants that utilize other non-essential insertion sites (and produce normal sized plaques), in terms of replication and expression of foreign genes in vitro (Yanagida et al., 1990 and in vivo (unpublished results). Position 25 is one of several non-essential insertion sites currently being used for the construction of candidate vaccines for poultry in our laboratory. Sequencing of the region surrounding the position 25 insertion site reveals that an ORF capable of encoding a polypeptide of 74K is disrupted by insertion of foreign DNA (Fig. 5) . The predicted protein product shares 24% amino acid identity with the vaccinia virus F12L ORF (Fig. 6a) . The function of the vaccinia virus ORF is not known, but based on the presence of two or three possible transmembrane sequences and seven potential N-glycosylation sites, it has been suggested that F12L may encode a membrane glycoprotein . The FPV homologue of F12L also possesses hydrophobic regions which may be transmembrane domains (Fig. 6b) and eight potential N-glycosylation sites (Fig. 6 a) . These characteristics are consistent with a role in the envelopment of virions by Golgi membranes and/or release of EEVs by fusion with the cytoplasmic membrane. Neither the FPV protein nor its vaccinia virus homologue has a hydrophobic amino terminus characteristic of a signal sequence.
A number of vaccinia virus genes have been reported to be associated with a small plaque phenotype, including a 14K envelope protein gene (Dallo et al., 1987; Pincus et al., 1992) , a gene related to regulators of complement activation (Takahashi-Nishimaki et al., 1991) , the vaccinia virus growth factor gene (Spyropoulos et al., 1991) , the SalL4R gene, which encodes a glycoprotein with homology to C-type animal lectins (Duncan & Smith, 1992) , and the p37K major envelope antigen gene (Blasco & Moss, 1992) . The 14K (Rodriguez & Smith, 1990) , p37K (Blasco & Moss, 1991) and SalL4R (Duncan & Smith, 1992) proteins are directly involved in envelopment and release of EEV from infected cells. The product of the vaccinia virus F12L ORF and its FPV homologue described here are not related to any of these proteins, although they may interact with them in the cooperative formation of enveloped virions.
Transcription in the poxviruses falls into three temporal categories, early, intermediate and late. Three transcriptional regulatory motifs have been identified in vaccinia virus and reviewed (Moss, 1990a; Moss et al., 1991) . These motifs appear to be conserved in FPV (Tomley et al., 1988; Kumar & Boyle, 1990a, b, c; Prideaux et al., 1990; Yanagida et al., 1992) . Early gene transcription is associated with an A-rich region beginning about 28 bp upstream from the RNA start site. The consensus sequence in this region is AAAAATG-AAAAAAAA, although known early promoters may deviate considerably from this consensus. The vaccinia virus F12L ORF and its FPV homologue both possess elements which resemble this consensus in appropriate upstream positions, AAAATAGAAAATAGA and ATATATGATAAAAAG, respectively (Fig. 5) . The sequence TTTTTNT functions as a terminator of early transcription in poxviruses, with termination occurring about 50 bp downstream from this motif (Yuen & Moss, 1987) . Thus, this sequence is not usually found within the coding region of early genes, and is often seen just downstream of such genes. The vaccinia virus F12L ORF does not contain the TTTTTNT motif within its coding region, but TTTTTAT does appear 20bp downstream of the TAA stop codon. The FPV homologue, in contrast, contains two internal TTTTTNT motifs but lacks this sequence near its 3 ~ terminus (Fig.  5) . Finally, transcription of known late genes usually starts within the sequence TAAAT (occasionally TAAAAT). The vaceinia virus F12L ORF does not possess such a motif immediately upstream from the ATG start codon (although TAAAT does exist 56 bp upstream, in the F13L ORF). The FPV homologue, on the other hand, has tandem overlapping late promoter motifs, TAAATAAAT, beginning 14 bp upstream of the start codon (Fig. 5) . It is possible that these differences in transcriptional regulatory motifs may result in differences in the temporal expression of the two genes. However, resolution of this question will require detailed transcriptional mapping studies in both viruses. program of the University of Wisconsin Genetics Computer Group (Devereux et al., 1984) . The mutation matrix of Gonnet et al. (1992) was employed, using an indel penalty of 10 and a gap extend penalty of 0.5. Identical amino acids are indicated by solid bars, strictly conserved residues (value >/+ 1.5 in this matrix) by double dots, and less conserved residues (value /> +0.1) by single dots. Potential N-glycosylation sites (N-X-S/T) are underlined. (b) Hydropathicity plot of the FPV p74K protein, using the method of Kyte & Doolittle (1982) , with a window size of 7. Hydrophobic regions have a negative value in this plot.
In addition to the FPV homologue of F12L, two partial ORFs were found in the sequenced DNA fragment. One of these potentially encodes a polypeptide of at least 252 residues, which is 38 % identical to the Cterminal two-thirds of the vaccinia virus major envelope antigen, p37K (Hirt et al., 1986) , which is the product of the F13L ORF. This partial ORF does not contain any TTTTTNT motifs. Cloning and sequencing of a fulllength copy of this gene from FPV, including upstream regulatory regions, has recently been completed in our laboratory (Calvert et al., 1992) . The second partial ORF potentially encodes 150 amino acids of the N termini of a protein of unknown function. Homology with F 11L or other vaccinia virus ORFs could not be demonstrated on the basis of this partial sequence.
Our method of using randomly chosen cloned fragments of viral DNA to find non-essential insertion sites for avipoxvirus vectors (Yanagida et at., 1990) does not require prior knowledge of the genomic positions of the fragments. However, the altered phenotype associated with position 25 recombinants made the location of this DNA fragment of interest. Because there is no published restriction enzyme map of an avipoxvirus genome for the enzyme HindIII, the genomic location of the cloned 5.7 kb HindIII fragment was not initially known. Southern blot hybridization analysis indicated that this fragment overlaps the 5.7 kb PstI M fragment near the centre of the genome, about 132 to 138 kb from the left end of a published restriction enzyme map (Coupar et al., 1990) . This location was confirmed by pulsed-field electrophoretic analysis of NotI-digested DNA from a recombinant with an altered lacZ gene. In vaccinia virus, the homologous region is part of the HindIII F fragment, located about 44 kb from the left end of the genome . Thus, although the contiguous head-to-tail organization of F 13L and F 12L in vaccinia virus is conserved in avipoxviruses, the genes are not found in the same region of the two viral genomes (regardless of whether one uses the centre or either end of the genomes as a reference point).
